BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37415169)

  • 1. The evolution of COVID-19 vaccine hesitancy in Sub-Saharan Africa: evidence from panel survey data.
    Wollburg P; Markhof Y; Kanyanda S; Zezza A
    BMC Proc; 2023 Jul; 17(Suppl 7):8. PubMed ID: 37415169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptance of COVID-19 vaccines in sub-Saharan Africa: evidence from six national phone surveys.
    Kanyanda S; Markhof Y; Wollburg P; Zezza A
    BMJ Open; 2021 Dec; 11(12):e055159. PubMed ID: 34911723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing COVID-19 vaccine hesitancy and barriers to uptake in Sub-Saharan Africa.
    Wollburg P; Markhof Y; Kanyanda S; Zezza A
    Commun Med (Lond); 2023 Sep; 3(1):121. PubMed ID: 37696937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccine hesitancy and its determinants among sub-Saharan African adolescents.
    Wang D; Chukwu A; Mwanyika-Sando M; Abubakari SW; Assefa N; Madzorera I; Hemler EC; Ismail A; Lankoande B; Mapendo F; Millogo O; Workneh F; Azemraw T; Febir LG; James C; Tinkasimile A; Asante KP; Baernighausen T; Berhane Y; Killewo J; Oduola AMJ; Sie A; Smith ER; Soura AB; Raji T; Vuai S; Fawzi WW
    PLOS Glob Public Health; 2022; 2(10):e0000611. PubMed ID: 36962540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of COVID-19 vaccine readiness and hesitancy among adults in sub-Saharan Africa.
    Abubakari SW; Workneh F; Asante KP; Hemler EC; Madzorera I; Wang D; Ismail A; Assefa N; Azemraw T; Lankoande B; Nuhu AR; Chukwu A; Mapendo F; Millogo O; Olufemi AA; Okpara D; Boudo V; Mwanyika-Sando M; Berhane Y; Baernighausen T; Oduola A; Vuai S; Sie A; Soura A; Killewo J; Tajudeen R; Fawzi WW; Smith ER
    PLOS Glob Public Health; 2023; 3(7):e0000713. PubMed ID: 37450441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Perception, Reasons, and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan Africa: A Mixed-Method Approach.
    Osuagwu UL; Langsi R; Ovenseri-Ogbomo G; Mashige KP; Abu EK; Envuladu EA; Goson PC; Ekpenyong BN; Oloruntoba R; Miner CA; Charwe DD; Timothy CG; Ishaya T; Amiebenomo OM; Lim D; Agho KE
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccine hesitancy in Africa: a scoping review.
    Ackah BBB; Woo M; Stallwood L; Fazal ZA; Okpani A; Ukah UV; Adu PA
    Glob Health Res Policy; 2022 Jul; 7(1):21. PubMed ID: 35850783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Vaccine Acceptance and Uptake in Bangkok, Thailand: Cross-sectional Online Survey.
    Remmel C; Tuli G; Varrelman TJ; Han AR; Angkab P; Kosiyaporn H; Netrpukdee C; Sorndamrih S; Thamarangsi T; Brownstein JS; Astley CM
    JMIR Public Health Surveill; 2023 Apr; 9():e40186. PubMed ID: 36811852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How prevalent is COVID-19 vaccine hesitancy in low-income and middle-income countries and what are the key drivers of hesitancy? Results from 53 countries.
    Dayton Eberwein J; Edochie IN; Newhouse D; Cojocaru A; Bopahbe GD; Kakietek JJ; Kim YS; Montes J
    BMJ Open; 2023 Nov; 13(11):e069152. PubMed ID: 37931970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine hesitancy among healthcare workers in low- and middle-income countries during the COVID-19 pandemic: Results from facility surveys across six countries.
    Baral P; Ahmed T; Amor Fernandez P; Peters MA; Drouard SHP; Muhoza P; Mwinnyaa G; Mwansambo C; Nzelu C; Tassembedo M; Uddin MH; Wesseh CS; Yansane ML; Bergeron JR; Karibwami AD; Lopez Chicheri TIOZ; Ogunlayi MIA; Sieleunou I; Hashemi T; Hansen PM; Shapira G
    PLoS One; 2023; 18(7):e0288124. PubMed ID: 37418435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on COVID-19 Vaccine Hesitancy in sub-Saharan Africa.
    Kabakama S; Konje ET; Dinga JN; Kishamawe C; Morhason-Bello I; Hayombe P; Adeyemi O; Chimuka E; Lumu I; Amuasi J; Acheampong T; Dzinamarira T
    Trop Med Infect Dis; 2022 Jul; 7(7):. PubMed ID: 35878142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers.
    Miner CA; Timothy CG; Percy K; Mashige ; Osuagwu UL; Envuladu EA; Amiebenomo OM; Ovenseri-Ogbomo G; Charwe DD; Goson PC; Ekpenyong BN; Abu EK; Langsi R; Oloruntoba R; Ishaya T; Agho KE
    BMC Public Health; 2023 Jan; 23(1):191. PubMed ID: 36709269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing hesitancy towards adult and child COVID-19 vaccines in rural and urban West Africa: a cross-sectional study.
    Faye SLB; Krumkamp R; Doumbia S; Tounkara M; Strauss R; Ouedraogo HG; Sagna T; Barry AM; Mbawah AK; Doumbia CO; Diouf S; Cisse K; Harding M; Donven P; May J; Puradiredja DI; Fusco D;
    BMJ Open; 2022 Apr; 12(4):e059138. PubMed ID: 35418436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine hesitancy against COVID-19 vaccine over time in Nigeria.
    Sato R
    Vaccine; 2023 Apr; 41(17):2749-2753. PubMed ID: 36959055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting data harmonization to evaluate vaccine hesitancy in LMICs: approach and applications.
    Rego RT; Zhukov Y; Reneau KA; Pienta A; Rice KL; Brady P; Siwo GH; Wachira PW; Abubakar A; Kollman K; Waljee AK
    BMC Med Res Methodol; 2023 Nov; 23(1):278. PubMed ID: 38001442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
    Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
    JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccine hesitancy and attitudes in Pakistan: a cross-sectional phone survey of major urban cities.
    Khan AA; Abdullah M; Aliani R; Mohiuddin AF; Sultan F
    BMC Public Health; 2023 Jun; 23(1):1112. PubMed ID: 37296386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates.
    Sallam M
    Vaccines (Basel); 2021 Feb; 9(2):. PubMed ID: 33669441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
    Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
    Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.